Bioqual (OTCMKTS:BIOQ) Releases Quarterly Earnings Results

Bioqual (OTCMKTS:BIOQ) issued its earnings results on Tuesday. The company reported ($1.36) earnings per share (EPS) for the quarter, Zacks reports. Bioqual had a negative return on equity of 7.37% and a negative net margin of 5.54%.

Bioqual Stock Down 0.8 %

Bioqual stock opened at $62.00 on Thursday. The company has a 50 day moving average price of $66.35 and a 200 day moving average price of $68.40. Bioqual has a 52 week low of $62.00 and a 52 week high of $80.00.

Bioqual Company Profile

Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.